Chronic Non-Cancer Pain

References

  1. Hooten M, Thorson D, Bianco J, et al. Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management. URL: https://www.icsi.org/guidelines__more/catalog_guidelines_and_more/catalog_guidelines/catalog_neurological_guidelines/pain/. Updated: August 2017. Accessed: June 22, 2020.
  2. Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by Different Types of Medicare Prescribers. JAMA Intern Med. 2016;176(2):259-261.
  3. Els C, Jackson TD, Hagtvedt R, et al. High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017.10:CD012299.
  4. Els C, Jackson TD, Kunyk D, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10:CD012509.
  5. Dowell, D, Haegerich TM, Chou, R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624-1645.
  6. Overdose death rates involving opioids, by type, United States, 2000-2017. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/drugoverdose/images/data/OpioidDeathsByTypeUS.PNG. Accessed: June 1, 2018.
  7. Voelker R. A Mandate for Opioid Education? JAMA. 2018;319(19):1974.
  8. American Society of Anesthesiologists Task Force on Chronic Pain Management. Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology. 2010;112:810-833.
  9. Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;4:CD011279.
  10. FDA News Release. US Food and Drug Administration website. URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367726.htm. Released: September 10, 2013. Accessed: June 28, 2016.
  11. Jena AB, Goldman D, Weaver L, Karaca-Mandic P. Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ. 2014;348:g1393.
  12. A prescriber’s guide to the new Medicare Part D opioid overutilization policies for 2019. Center For Medicare and Medicaid Services website. URL: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/se18016.pdf. Published: November 1, 2018. Accessed: June 25, 2018.
  13. Kroenke K, Alford DP, Argoff C, et al. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report. Pain Med. 2019;20(4):724-735.
  14. Dowell D, Haegerich T, Chou R. No Shortcuts to safer opioid prescribing. New Engl J Med. 2019;380:2285-2287.
  15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Publishing; 2013.
  16. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. US Department of Health and Human Services. URL: https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf. Published: October 2019. Accessed: June 23, 2020.